Provided is a cellulose derivative composition for a secondary battery binder, a method of preparing a composition for a secondary battery electrode, including the same, and a secondary battery including the same. According to the inventive concept, the cellulose derivative composition for a secondary battery binder may include a compound represented by Formula 1 below. ##STR00001##

The present document describes a process for the preparation of a low functionalization polysaccharide having carboxyl groups, comprising a) swelling of a polysaccharide granule in boiling water or a water/polyol mixture, to obtain a swollen polysaccharide; b) partial gelatinization of said swollen polysaccharide in an alkaline solvent mixture of water and alcohol and/or polyol, to obtain a partially gelatinized polysaccharide; and c) partial functionalization of said partially gelatinized polysaccharide with a functionalizing agent, to obtain the low functionalization polysaccharide.

The present invention provides amidic polymers, which exhibit shale swelling inhibitor activity having improved bio-degradability. The amidic polymers of the invention may be employed in a wide variety of compositions, particularly in subterranean drilling operations. Non-limiting generic structures of the amidic polymers are set out below: (1) wherein R.sub.1-R.sub.3 and integers m and n are defined herein.

##STR00001##

The present invention relates to a process for preparing control agents for applications in the petroleum field, where a polymer bearing OH, amine and/or amide functions, which is in the form of a divided solid, is reacted with at least one crosslinking agent bearing at least two R groups capable of reacting with the OH, amine or amide groups, under conditions where said polymer remains in solid form and where said crosslinking agent is at least partly in vapor form, The invention also relates to the control agents obtained in solid form according to this process, and also to the mixtures of these solid agents with other additives, which can be used in particular for the preparation of cement grout for oil extraction.

The present invention provides amidic polymers, which exhibit shale swelling inhibitor activity having improved biodegradability. The amidic polymers of the invention may be employed in a wide variety of compositions, particularly in subterranean drilling operations. Non-limiting generic structures of the amidic polymers are set out below: formula (1) wherein R.sub.1-R.sub.3 and integers m and n are defined herein. ##STR00001##

A method for installing an in situ, low-permeability temporary horizontal barrier at depth for vertical containment of a soil mass including installing a low permeability vertical barrier having walls located to contain a predetermined soil volume, the vertical barrier having a horizontal surface area in a plane perpendicular to its walls; and injecting low permeability reagents capable of forming a temporary horizontal barrier in a pattern suitable for creating a horizontal subsurface barrier joined to all of the vertical barrier walls to form an in situ barrier.

The production of a diutan polysaccharide exhibiting increased viscosity properties as compared with previously produced polysaccharide of the same type of repeating units. Such an improved diutan polysaccharide is produced through the generation of a derivative of Sphingomonas sp. ATCC 53159 that harbors a multicopy broad host-range plasmid into which genes for biosynthesis of diutan polysaccharide have been cloned. The inventive methods of production of such an improved diutan polysaccharide, as well as the novel cloned genes required to produce the improved diutan within such a method, are also encompassed within this invention. Additionally, the novel engineered Sphingomonas strain including the needed DNA sequence is encompassed within this invention.

Described herein are hemi-aminal ethers and thioethers of N-alkenyl cyclic compounds that may be produced through a reaction comprising: (A) at least one first reactant represented by a structure (I), wherein X is a functionalized or unfunctionalized C.sub.1-C.sub.5 alkylene group optionally having one or more heteroatoms, and each R.sub.1, R.sub.2, and R.sub.3 is independently selected from the group consisting of hydrogen and functionalized and unfunctionalized alkyl groups optionally having one or more heteroatoms, and (B) at least one second reactant having at least one hydroxyl moiety or thiol moiety. The hemi-aminal ethers and thioethers of N-alkenyl cyclic compounds may comprise a polymerizable moiety, in which case they may be left as-is or used to create homopolymers or non-homopolymers, or they may not comprise a polymerizable moiety. A wide variety of formulations may be created using the hemi-aminal ethers and thioethers of N-alkenyl cyclic compounds, including personal care, oilfield, and construction formulations. ##STR00001##

A modification of natural or synthetic polysaccharides by grafting polyetheramines, and the use of modified polysaccharides in the form of a hydrogel as a medium for cell culture. These hydrogel preparations may have heat-sensitive rheological properties that are interesting for their intracorporeal use in human and veterinary medicine, for cell culture and transport of biological samples.

Therapeutic compositions and/or formulations are provided, comprising: at least one cross-linked protein matrix, wherein the at least one cross-linked protein matrix comprises at least one protein residue and at least one saccharide-containing residue, and methods of producing the same. The cross-linked protein matrix may be derived from cross-linking a full length or substantially full length protein, such as tropoelastin, elastin, albumin, collagen, collagen monomers, immunoglobulins, insulin, and/or derivatives or combinations thereof, with a saccharide containing cross-linking agent, such as a polysaccharide cross-linking agent derived from, for example, hyaluronic acid or a cellulose derivative. The therapeutic compositions may be administered topically or by injection. The present disclosure also provides methods, systems, and/or kits for the preparation and/or formulation of the compositions disclosed herein.